Tiagabine prevents seizures, neuronal damage and memory impairment in experimental status epilepticus

European Journal of Pharmacology

Volumn 299, Issue 1-3, 1996, Pages 69-81

  Halonen, Toivo ^a   Nissinen, Jari ^a   Jansen, Jens A ^b   Pitkänen, Asla ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b NOVO NORDISK A S   (Denmark)

Author keywords

Epilepsy; GABA ( aminobutyric acid); Hippocampus; Neuroprotection; Perforant pathway stimulation

Indexed keywords

4 AMINOBUTYRIC ACID; ASPARTIC ACID; GLUTAMIC ACID; PENTETRAZOLE; TIAGABINE;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN PROTECTION; CEREBROSPINAL FLUID LEVEL; CLONIC SEIZURE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; ELECTROSTIMULATION; EPILEPTIC STATE; HIPPOCAMPUS; HISTOLOGY; MALE; MAZE TEST; NERVE CELL LESION; NONHUMAN; OSMOTIC MINIPUMP; PERFORANT NERVE TRACT; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; SPATIAL MEMORY; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029885743     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00835-7     Document Type: Article

References (41)

1. Babb, T.L. and J.K. Pretorius, 1993, Pathological substrates of epilepsy, in: The Treatment of Epilepsy: Principles and Practice, ed. E. Wylie (Lea and Febiger, Philadelphia) p. 55.
2. Bornstein, R.A., A. Pakalnis, M.E. Drake Jr. and L.J. Suga, 1988, Effects of seizure type and waveform abnormality on memory and attention, Arch. Neurol. 45, 884.
3. Braestrup, C., E.B. Nielsen, U. Sonnewald, L.J.S. Knutsen, K.E. Andersen, J.A. Jansen, K. Frederiksen, P.H. Andersen, A. Mortensen and P.D. Suzdak, 1990, NO-328 binds with the high affinity to the brain GABA uptake carrier, J. Neurochem. 54, 639.
4. Cavazos, J., G. Golarai and T. Sutula, 1991, Mossy fiber synaptic reorganization induced by kindling: time course of development, progression and permanence, J. Neurosci. 11, 2795.
5. Cavazos, J.E., L. Das and T.P. Sutula, 1994, Neuronal loss induced in limbic pathways by kindling: evidence for induction of hippocampal sclerosis by repeated brief seizures, J. Neurosci. 14, 3106.
6. Chadwick, D., A. Richens, J. Duncan, M. Dam, L. Gram, J. Morrow, H. Mengel, V. Shu, J.F. McKelvy and M.W. Pierce, 1991, Tiagabine HCl safety and efficacy as adjunctive treatment for complex partial seizures, Epilepsia 32 (Suppl. 3), 20.
7. DeGiorgio, C.M., U. Tomiyasu, P.S. Gott and D.M. Treiman, 1992, Hippocampal pyramidal cell loss in human status epilepticus, Epilepsia 33, 23.
8. Faingold, C.L., M.E. Randall and C.A. Boersma Anderson, 1994, Blockade of GABA uptake with tiagabine inhibits audiogenic seizures and reduces neuronal firing in the inferior colliculus of the genetically epilepsy-prone rat, Exp. Neurol. 126, 225.
9. Fink-Jensen, A., P.D. Suzdak, M.D.B. Swedberg, M.E. Judge, L. Hansen and P.G. Nielsen, 1992, The γ-aminobutyric acid (GABA) uptake inhibitor, tiagabine, increases extracellular brain levels of GABA in awake rats, Eur. J. Pharmacol. 220, 197.
10. Freund, T.F., A. Ylinen, R. Miettinen, A. Pitkänen, H. Lahtinen, K.G. Baimbridge and P.J. Riekkinen, 1991, Pattern of neuronal death in the rat hippocampus after status epilepticus. Relationship to calcium binding protein content and ischemic vulnerability, Brain Res. Bull. 28, 27.
11. Gallyas, F., J.R. Wolff, H. Böttcher and L. Zaborsky, 1980, A reliable and selective method to localize terminal degeneration and lysosomes in the central nervous system, Stain Technol. 55, 299.
12. Gloor, P., 1991, Mesial temporal sclerosis: historical background and an overview from a modern perspective, in: Epilepsy Surgery, ed. H. Luders (Raven Press, New York) p. 689.
13. Grant, S.M. and R.C. Heel, 1991, Vigabatrin, a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control, Drugs 41, 889.
14. Grove, J., M.G. Palfreyman and P.J. Schechter, 1983, Cerebrospinal fluid GABA as an index of brain GABA activity, Clin. Neuropharmacol. 6, 223.
15. Gustavson, L.E. and S.-Y. Chu, 1992, High-performance liquid chromatographic procedure for the determination of tiagabine concentrations in human plasma using electrochemical detection, J. Chromatogr. 574, 313.
16. Halonen, T., A. Pitkänen, V. Saano and P.J. Riekkinen, 1991, Effects of vigabatrin (γ-vinyl GABA) on neurotransmission-related amino acids and on GABA and benzodiazepine receptor binding in rats, Epilepsia 32, 242.
17. Jolkkonen, J., L. Tuomisto, T.B. Van Wimersma Greidanus, E. Läärä and P.J. Riekkinen, 1986, Vasopressin levels in the cerebrospinal fluid in rats of different age and sex, Neuroendocrinology 44, 163.
18. Lencz, T., G. McCarthy, R.A. Bronen, T.M. Scott, J.A. Inserni, K.J. Sass, R.A. Novelly, J.H. Kim and D.D. Spencer, 1992, Quantitative magnetic resonance imaging in temporal lobe epilepsy: relationship to neuropathology and psychopharmacological function, Ann. Neurol. 31, 629.
19. 1-12 in monkey prefrontal cortex, J. Comp. Neurol. 212, 293.
20. Lorente de No, R., 1934, Studies on the structure of the cerebral cortex. II. Continuation of the study of the ammonic system, J. Psychol. Neurol. 46, 113.
21. Mathern, G.W., T.L. Babb, B.G. Vickrey, M. Melendez and J.K. Pretorius, 1995, The clinico-pathogenic mechanisms of hippocampal neuron loss and surgical outcomes in temporal lobe epilepsy, Brain 118, 105.
22. Mikati, M.A., G.L. Holmes, A. Chronopoulos, P. Hyde, S. Thurber, A. Gatt, Z. Liu, S. Werner and C.E. Stafstrom, 1994, Phenobarbital modifies seizure-related brain injury in the developing brain, Ann. Neurol. 36, 425.
23. Morris, R.G.M., P. Garraud, J.N.P. Rawlis and J. O'Keefe, 1982, Place navigation impaired in rats with hippocampal lesions, Nature 297, 681.
24. Mourizen-Dam, A., 1980, Epilepsy and neuron loss in the hippocampus, Epilepsia 21, 617.
25. Nielsen, E.B., P.D. Suzdak, K.E. Andersen, L.J.S. Knutsen, U. Sonnewald and C. Braestrup, 1991, Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitor, Eur. J. Pharmacol. 196, 257.
26. Paxinos, G. and C. Watson, 1986, The Rat Brain Stereotaxic Coordinates (Academic Press, New York).
27. Pitkänen. A. and T. Halonen, 1994, Prevention of neuronal cell damage in the temporal lobe by vigabatrin and carbamazepine in experimental status epilepticus, Epilepsia 35 (Suppl. 8), 64.
28. Racine, R.J., 1972, Modification of seizure activity by electrical stimulation. II. Motor seizures, Electroencephalogr. Clin. Neurophysiol. 32, 281.
29. Richens, A., D. Chadwick, J. Duncan, M. Dam, J. Morrow, L. Gram, H. Mengel, V. Shu, M. Pierce, C. Rask and B. Hightower, 1992, Safety and efficacy of tiagabine HCl as adjunctive treatment for complex partial seizures, Epilepsia 33 (Suppl. 3), 119.
30. Riekkinen Jr., P., J. Sirviö and P. Riekkinen, 1990, Similar memory impairments found in medial septal-vertical diagonal band of Broca and nucleus basalis lesioned rats: are memory defects induced by nucleus basalis lesions related to the degree of non-specific subcortical cell loss?, Behav. Brain Res. 37, 81.
31. Saukkonen, A., R. Kälviäinen, K. Partanen, P. Vainio, P. Riekkinen and A. Pitkänen, 1994, Do seizures cause neuronal damage? A MRI study comparing the volumes of the hippocampus, amygdala and parahippocampal gyrus in newly diagnosed and chronic epilepsy, NeuroReport 6, 219.
32. Sloviter, R.S., 1983, 'Epileptic' brain damage in rats induced by sustained electrical stimulation of the perforant path. I. Acute electrophysiological and light microscopic studies, Brain Res. Bull. 10, 675.
33. Sloviter, R.S., 1987, Decreased hippocampal inhibition and a selective loss of interneurons in experimental epilepsy, Science 235, 73.
34. Sloviter, R.S., 1994, The functional organization of the hippocampal dentate gyrus and its relevance to the pathogenesis of temporal lobe epilepsy, Ann. Neurol. 35, 640.
35. Smith, S.E., N.S. Parvez, A.G. Chapman and B.S. Meldrum, 1995, The γ-aminobutyric acid uptake inhibitor, tiagabine, is anticonvulsant in two animal models of reflex epilepsy, Eur. J. Pharmacol. 273, 259.
36. Sutherland, R.J., I.Q. Whishaw and B. Kolb, 1983, A behavioural analysis of spatial localization following electrolytic-, kainate- or colchicine-induced damage to the hippocampal formation in the rat, Behav. Brain Res. 7, 133.
37. Sutula, T., J. Cavazos and G. Golarai, 1992, Alteration of long-lasting structural and functional effects of kainic acid in the hippocampus by brief treatment with phenobarbital, J. Neurosci. 12, 4173.
38. Suzdak, P.D. and J.A. Jansen, 1995, A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor, Epilepsia 36, 612.
39. 2-adrenergic drugs dexmedetomidine and atipamezole on extracellular amino acid levels in vivo, Eur. J. Pharmacol. 285, 239.
40. Walton, N.Y., S. Gunawan and D.M. Treiman, 1994, Treatment of experimental status epilepticus with the GABA uptake inhibitor, tiagabine, Epilepsy Res. 19, 237.
41. Ylinen, A.M.A., R. Miettinen, A. Pitkänen, A.I. Gulyas, T. Freund and P.J. Riekkinen, 1991, Enhanced GABAergic inhibition preserves hippocampal structure and function in a model of epilepsy, Proc. Natl. Acad. Sci. USA 88, 7650.